BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10812643)

  • 21. Autologous transplantation with peripheral blood stem cells: a review of clinical results.
    Kessinger A
    J Clin Apher; 1990; 5(2):97-9. PubMed ID: 1967604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autologous hematopoietic stem cell transplantation].
    Nemet D
    Acta Med Croatica; 2009 Jun; 63(3):219-25. PubMed ID: 19827349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An analysis of autologous peripheral stem cell transplantation for hematological malignancies].
    Ke X; Yang Y; Zhao X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):586-8. PubMed ID: 11721377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.
    Olivieri A; Capelli D; Montanari M; Brunori M; Massidda D; Poloni A; Lucesole M; Centurioni R; Candela M; Masia MC; Tonnini C; Leoni P
    Bone Marrow Transplant; 2001 Jun; 27(11):1189-95. PubMed ID: 11551030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
    Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allogeneic peripheral blood stem cell transplantation in the treatment of hematologic malignancies].
    Wang F; Huang X; Ren H; Zhang Y; Xu L; Chen Y; Liu K; Guo N; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):403-6. PubMed ID: 12411042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome.
    Fanin R; Sperotto A; Ruiz De Elvira C; Zaja F; Stocchi R; Geromin A; Cerno M; Patriarca F; Fanni Canelles M; Damiani D; Baccarani M
    Haematologica; 2000 Sep; 85(9):943-51. PubMed ID: 10980633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autologous stem cell transplantation in haematological disorders,1980-2002].
    Beckers MM; Verdonck LF; Cornelissen JJ; Schattenberg AV; Janssen JJ; Willemze R; van Imhoff GW; van der Lelie JH; Wijermans P; Schaafsma R; Baars J; van Marwijk Kooij MR; Biesma DH; van Biezen A; Brand R; Schouten HC
    Ned Tijdschr Geneeskd; 2010; 154():A2025. PubMed ID: 20977803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
    Corradini P; Dodero A; Zallio F; Caracciolo D; Casini M; Bregni M; Narni F; Patriarca F; Boccadoro M; Benedetti F; Rambaldi A; Gianni AM; Tarella C
    J Clin Oncol; 2004 Jun; 22(11):2172-6. PubMed ID: 15169805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.
    Magagnoli M; Castagna L; Balzarotti M; Sarina B; Timofeeva I; Bertuzzi A; Compasso S; Nozza A; Siracusano L; Santoro A
    Am J Hematol; 2003 Aug; 73(4):267-72. PubMed ID: 12879431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R; Van Heijzen K; Palmer A; Komiya A; Slovak ML; Chang KL; Fung H; Krishnan A; Molina A; Nademanee A; O'Donnell M; Popplewell L; Rodriguez R; Forman SJ; Bhatia S
    J Clin Oncol; 2005 Sep; 23(27):6699-711. PubMed ID: 16170178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.
    Jantunen E; Itälä M; Siitonen T; Koivunen E; Leppä S; Juvonen E; Kuittinen O; Lehtinen T; Koistinen P; Nyman H; Nousiainen T; Volin L; Remes K
    Eur J Haematol; 2006 Aug; 77(2):114-9. PubMed ID: 16856906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
    Petersen EJ; Lokhorst HL; Verdonck LF
    Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2328-32. PubMed ID: 14669540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An analysis of double autologous hemopoietic stem cell transplantation for hematological malignancies].
    Zhang B; Huang W; Da W; Zhang Z; Yao S; Gao C; Han X; Wu X; Wang Q; Yu L; Zhang M; Jin H
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):123-6. PubMed ID: 11953143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.